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We studied the outcome of 436 patients with primary 
biliary cirrhosis (PBC) or primary sclerosing cholangitis 
(PSC) who underwent orthotopic liver transplant (OLT) 
at three major liver transplant centers. Univariate pre-
dictors of outcome included age, Karnofsky score, 
Child's class, Mayo risk score, United Network for Organ 
Sharing (UNOS) status, nutritional status, serum albu-
min, serum bilirubin, international normalized ratio, 
and the presence of ascites, encephalopathy, renal fail-
ure (serum creatinine> 2 mg/dL), and edema refractory 
to diuretics. Using these predictors, we developed a four 
variable mathematical prognostic model to help the 
liver transplant physician predict the following: 1) the 
amount of intraoperative blood loss; 2) the number of 
days in the intensive care unit (ICU); and 3) severe com-
plications after surgery. The model uses age, renal fail-
ure, Child's class, and United Network for Organ Shar-
ing status. This study is the first to model the outcome 
of liver transplant in patients with a specific etiology of 
chronic liver disease (PBC or PSC). The model may be 
used to help select patients for OL T and to plan the tim· 
ing of their transplantation. (HEPATOLOGY 1997;25:672· 
677.) 
In the early 1980s, orthotopic liver transplant (OLT) was 
recognized to prolong survival in patients with chronic liver 
disease; today it is accepted therapy for end-stage liver dis-
ease due to a variety of etiologies.' However, as the number of 
accepted indications for liver transplantation has increased, 
there has not been a corresponding increase in the number 
of suitable organ donors. This has resulted in a disparity 
between donor organ demand and supply that has grown 
d~amatically over the past few years. In 1993, 560 patients 
dIed on the liver transplantation waiting list in the U.S.2 
Transplantation physicians, who deal with progressively 
longer waiting lists, need to decide which patients to select 
for liver transplantation and when to enter those patients 
onto a waiting list. These decisions need to coincide for a 
transplantation to occur at a timely point in the patient's 
disease course. 
The present allocation system assigns donor livers to the 
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patients with most advanced disease, resulting in a longer 
waiting time for less advanced patients. The clinical status 
of these patients inevitably deteriorates as their waiting time 
lengthens.3 Since the postoperative' course of patients who 
are end-stage at the time of transplantation is characterized 
by higher mortality, morbidity, and cose-6; this deferral of 
all patients until their status is terminal has a negative im-
pact upon liver transplantation outcome. Recognizing that 
not every patient can be transplanted, there is a need for 
methods which will allow transplantation physicians to pre-
dict which patients will most benefit from transplantation. 
For the referring physicians, the knowledge of factors that 
lead to poor OLT outcome may enable them to better plan 
their referrals. 
This paper reports the predictors of post-OLT morbidity, 
as the survival of transplanted patients has improved and 
become medically acceptable.2 Indeed, the risk factors for pa-
tient and graft survival could not be assessed as there were 
not enough events for adequate modeling. We studied the 
outcome of 436 patients who received a liver transplant for 
primary biliary cirrhosis (PBC) or primary sclerosing cholan-
gitis (PSC). First, we examined the relationship between se-
lected preoperative variables and intraoperative blood loss, 
and postoperative morbidity (intensive care unit [lCU] stay 
and major complications after OLT). Second, we developed a 
mathematical prognostic model, containing four inexpensive 
and easily obtained variables, that the liver transplant physi-
cian can use to calculate a score for predicting the patient's 
intraoperative blood loss and postoperative morbidity. 
PATIENTS AND METHODS 
Methods. We followed 436 patients with established PBC (n = 228) 
or PSC (n = 208) who underwent OLT between 1985 and 1994 at 
either the Baylor University Medical Center (BUMC, Dallas, TX), 
the University of Pittsburgh (Pittsburgh, PAl, or the Mayo Clinic 
(Rochester, MN). The National Institutes of Health Liver Transplant 
Database forms were the source of the data. These forms were in 
use at the University of Pittsburgh and Mayo Clinic from 1990 until 
present. Similar fonns were in use at Baylor University Medical 
Center since 1985. 
Follow-up data are shown in Table 1. The median follow-up time 
was 2 years post-OLT. The higher absolute number of retransplants 
and deaths at Baylor University Medical Center reflects their longer 
patient series extending over a 10-year period. Table 2 reports pa-
tient demographic, clinical, and biochemical characteristics along 
with OLT outcome variables. It includes the following 13 preopera-
tive variables that were studied: age, Child's class, Karnofsky score, 
Mayo risk score, United Network for Organ Sharing (UNOS) status, 
nutritional status, serum albumin, serum bilirubin, international 
normalized ratio and the presence of ascites, encephalopathy, renal 
failure (serum creatinine> 2 mg/dL), and edema refractory to diuret-
ics. Table 2 reports the following: patient mean age was 51 years; 
68% were female: 52'7c had PBC; 83% belonged to Child class B or 
C; 68% had ascites; 28% had edema refractory to diuretics; 48% had 
encephalopathy: and 9'7c had renal failure defined as serum creati-
nine> 2 mg/dL. The UNOS status shows that 27'7c of patients were 
at home; 52'7c received continuous medical care; 16'7c were hospital-
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TABLE 1. Follow-Up Data for Patients Who Underwent Liver 
Transplantation for PBC or PSC 
University of 
BUMC Pittsburgh Mayo Clinic All Patients 
(n = 194) (n = 136) (n = 106) (n = 436) 
Transplantation dates 
First 4122185 8/1/90 4/21/90 
Last 9/2194 1/11/95 4/25/94 
Retransplants (nl* 25 8 10 43 
Death. lnl 30 12 5 47 
Last follow-up date 1119194 2125/95 4/12/95 
Median follow-up (yl 3.1 1.0 2.1 2.0 
Abbreviation: BUMC, Baylor University Medical Center. 
* Number of patients who underwent one or more retransplants after failure 
of the initial OLT. 
ized; and 5% were in ICU at the time of liver transplant. Median 
Mayo PBC risk score was 7.3 (range, 4.2-10.3) and for PSC the me-
dian risk score was 5.4 (range, 2.9-7.1). 
Table 2 also reports the four transplant outcomes as follows: intra-
operative blood use (amount of transfused fresh frozen plasma, 
packed red blood cells, and cell saver), number of days in an ICU, 
severe complications within 30 days of OLT, and severe complica-
tions that occur after 30 days from OLT. Severe complications in-
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eluded retransplantation. patient death, and any medical event 
prompting the patient management team to respond with diagnostic 
or therapeutic action. For example, an infection was treated with a 
course of antibiotics or a biliary leak was corrected with a percutane-
ous, endoscopic, or surgical procedure. Medical problems requiring 
therapeutic intervention, but unrelated to the transplant surgery 
itself or to the side effects of immunosuppressive drugs, were not 
considered as complications and were not included in the outcomes. 
The differences in mean and median outcomes among the three insti-
tutions shown in Table 2 may ref1ect differences in data collection 
and coding practices. Table 3 reports the types of complications that 
occurred after OLT. As reported, infections have the highest fre-
quency. 
Statistical Analysis. All statistical analyses were performed using 
the SAS7 and S-PLUS8 packages. Inter-center differences in demo-
graphic variables were compared using the rank sum and binomial 
tests. Overall patient and graft survival were computed by the 
Kaplan-Meier method. Each outcome (blood loss, ICU days, early 
and late complications) was analyzed separately. Univariate and 
multivariate examinations of blood loss and ICU days were based on 
linear regression with a logarithmic transformation of the dependent 
variable. Complications were examined using Poisson regression, ac-
counting for both the differential amount of follow-up for each patient 
and the decreasing overall rate of events during the months following 
OLT. Because of possible differences among the transplant centers 
in coding and recording these variables, particularly in the local 
interpretation of what constitutes a "severe" complication, all models 
were adjusted for both institution and diagnosis (PBC or PSC). The 
TABLE 2. Demographic, Clinical, Biochemical Features, and Outcomes in Patients Who Underwent 
Liver Transplantation for PBC or PSC 
University of Pittsburgh 
BUMC (n = 194) (n = 136) 
Demographic 
Age (y) (mean:!: sm 49:!: 10 53:!: 12 
Sex (% female) 72 66 
Liver disease (% PBC) 56 57 
Clinical 
Ascites, (%) 69 63 
Child's-Pugh class, (%) 
A 17 20 
B 53 58 
C 30 21 
Edema l%l* 31 19 
Encephalopathy, l'ic) 58 45 
Karnofsky score (median It 70 50 
Mayo risk score (median) 
PBC 7.2 7.2 
PSC 5.4 
Nutritional status (%) 
Excellent 20 50 
Fair 66 41 
Poor 14 9 
Renal failure (%I:j: 8 11 
UNOS status l%) 
ICUlliver failure (1) 9 4 
Hospitalized l2) 13 26 
Continuous medical care 13 I 48 62 
.-\t home l41 30 8 
"'nemical (median) 
dbumin (gILl 3.3 3.3 
Bilirubin Img/dL) 6.6 4.6 
INR l.2 1.3 
OLT outcomes 
Operative blood loss. liters (median) 1.1 3.3 
ICU. days (median) 3 6 
Severe complications (X :': sm§ 0.9 :!: 1.5 1.2:': :1.1 
Severe complications ( x :': SD)" 1.4 :': 2.1 1.2 :': 2.2 
Abbreviations: INR. international normalized ratio; BUMC. Baylor University Medical Cent"r . 
• Edema despite diuretic therapy. 
7 High Karnofsky indicated healthier patient. 
t Creatinine >2 mgldL and/or urine output -: 10 mLikg!24 hour,,_ 
* Medical event requiring intervention Within :30 days of OLT "urgery. 
;"ledical event requiring intervention more than :.W da:\'s aftt.·r OLT "'Uq.rl·~· 
Mayo Clinic All Patients 
(n = 106) (n = 436) 
50 :!: 10 51:!: 11 
64 68 
40 52 
74 68 
13 17 
44 52 
42 31 
35 28 
36 48 
70 60 
7.9 7.3 
5.5 5.4 
16 28 
67 59 
16 1:3 
9 9 
0 fi 
4 16 
42 52 
54 27 
2.9 ;3.2 
7.9 6.3 
1.3 1.:1 
4.0 ~.2 
:3 :3 
IS ~. 2.0 1.2 • U) 
:1.:1'_ :1.7 I.H . :.!.7 
-.------"-----.. ---~~ 
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Blood usage 
Days in leu 
2.80 
Adverse events. :s 30 days 
Adverse events. > 30 dayF. 
Q) 2.00 
.~ 
(/) 
-
1.40 0 Q) 
-W 1.00 
I~ ~ 0.71 
net effect of these procedures is that the final models are multiplica-
tive. That is, a coefficient of 1.25 for ascites means that a patient 
with ascites is expected to have 25% more complications than a pa-
tient without ascites. The final models were verified using the robust 
regression methods of Chambers and Hastie9 to ensure that no single 
case (outlier) had an undue effect on the estimates. 
Univariate Analysis. Figure 1 reports the univariate effect of a 
risk factor on a particular outcome. For the continuous variables of 
age, Karnofsky, Mayo r score, albumin, bilirubin, and international 
normalized ratio Fig. 3 reports the effect on two patients: one at the 
25th percentile and the other at the 75th percentile. 
Multivariate Analysis. Our goal was to select a simple model that 
would be applicable to each outcome. That is, we preferred not to 
have one set of variables for predicting blood loss, another to predict 
ICU days, and yet a third to predict complications; however, the 
relative weight of each variable within the model might vary among 
outcomes. Because the variables shown in Fig. 1 are highly interde-
pendent, stepwise regression methods can be very misleading, ie, the 
deletion of only a few patients can lead to selection of a completely 
different set of variables.1O First, stepwise regression was used to 
determine that a four-variable multivariate model would provide the 
hest prediction (a five-variable model was not significantly better 
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FIG. 1. Univariate analysis: pre-
dictors of operative and postoperative 
outcome. 
than a four-variable model), Second, the bootstrap method was used 
to assess which three- or four-variable models were similar, in pre-
dictive accuracy, to the "best" model chosen by the stepwise proce-
dure, For blood usage, for example, it selected 38 of the 715 possible 
four-variable combinations and 2 of the 286 possible three variable 
combinations. Models were considered equivalent if their r statistics 
were within .5 standard error of each other. This was repeated for 
each outcome. The final model was one which was closest to the 
"best" model in all three categories of outcome. 
RESULTS 
Survival. Overall 2-year patient survival was 90% (Fig. 
2A). Overall 2-year graft survival was 82% (Fig. 3A), There 
was no statistically significant difference between PBC and 
PSC in the surviving proportion of patients (P = .71) and 
grafts (P = .66), as shown in Figs. 2B and 3B. 
Univariate Analysis. The univariate analyses are shown in 
Fig. 1. The variables studied are represented on the x axis 
and their estimated multiplicative effect (with 95% confi-
dence intervals) for the four outcomes is displayed on the y 
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TABLE 3, Types of Severe Complications Among Patients Who 
Underwent Liver Transplantation for PBC or PSC 
~c:30 Days After OLT . ·30 Days After OLT 
(n ~ 521) (n ~ 775) 
Complication Type* (%) (%) 
Infectious 23 38 
Abdominal 13 8 
Biliary 10 9 
Cardiac 8 2 
Renal 8 6 
Graft Failure 6 <1 
Vascular 6 4 
GI 5 3 
Neuro/Psych 5 2 
Pulmonary 5 2 
Circulatory 4 <1 
Retransplant 4 4 
Surgical 2 1 
Death 2 5 
Other 15 
Metabolic!Endo 0 <1 
Neoplasm 0 <1 
Abbreviation: GI, gastrointestinal. 
* Medical events requiring some intervention. 
axis. The dashed line at 1.00 represents the outcome ofliver 
transplantation for an "average" PBC or PSC patient at the 
respective medical center. Increasing Karnofsky score, UNOS 
status, and albumin have a positive effect on outcome (a rate 
< 1); increasing values of all the other variables cause an 
increase in the amount of blood, days in ICU, or number of 
complications. For example, the presence of pretransplant 
ascites is associated with a 35% increase in the blood usage 
during surgery, a 27% increase in the number of ICU days, 
and a 46% increase in the number of major complications 
within 30 days oftransplantation. The change in longer term 
complication rate (>30 days after OLT) was not statistically 
significant, as shown by a confidence interval that straddles 
1.0. The effect of each predictor on the first three outcomes 
is remarkably consistent, ie, the estimated effect on ICU 
days, for example, is almost always within the confidence 
limit for blood usage and complications effects. The confi-
dence intervals for complications are somewhat wider, re-
flecting the more uncertain nature of that measurement. 
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TABLE 5. Coefficients for Calculations of Blood Usage Score, ICU 
Score and Complications Score. and Examples of Calculating These 
Scores and Their Effects 
Complications $30 
Blood Usage Score ICU Score Days Score 
Constant 45.0 -,18.0 -57.0 
Age (y) l.0 1.1 l.8 
Renal failure* 19.0 63.0 53.0 
Child's ClassT 29.0 25.0 12.0 
UNOS statust -2l.0 
-19.0 -19.0 
NOTE. Example l. 60-year-old with normal renal functioning, a modified 
Child's score of 8, and hospitalized. 
Blood usage score = -45.0 + l.0*60 + 19.0*0 + 29.0*2 - 2l.0'2 ~ 3l.0 
Blood use effect = exp[(31.0/100)] = l.36 
ICU score = -48.0 + l.1 *60 + 63.0*0 + 25.0*2 -- 19.0*2 = 30.0 
ICU effect = exp[(30.0/100)] = l.35 
Complications score = -57.0 + l.8*60 + 53.0*0 + 12.0*2 -19.0*2 = 37.0 
Complications effect = exp[(37.0/100)] = 1.45. 
Example 2. 45-year-old, with creatinine mg/dL = 2.1, Child's C and in the 
ICU. 
Blood usage score = -45.0 + l.0*45 + 19.0*1 + 29.0*3 - 21.0*1 = 85.0 
Blood use effect = expl(85.0/100)] = 2.34 
ICU score = . 48.0 + 1.1*45 + 63.0*1 + 25.0*3 - 19.0*1 = 20.5 
ICU effect = exp[(20.5/100)] = 3.34 
Complications score = -57.0 + 1.8*45 + 53.0*1 + 12.0*3 - 19.0*1 = 
94.0 
Complications effect = exp[(94.0/100)] = 2.56. 
* Coded: 0 for normal renal function and 1 for renal failure (creatinine mg/ 
dL >2.0 andlor urine output <10 mIlkg/24 hrs). 
t Coded: 1 for Child's A or Modified Child's $7; 2 for Child's B or modified 
Child's >7 and <11; and 3 for Child's C or modified Child's ;;;,;11. Modified 
Child's Classification: Mayo Clinic Proceedings, March 85, Vol. 60. 
t Coded: 1) ICUlliver failure; 2) hospitalized; 3) continuous care; and 4) at 
home (coding is consistent with the May '95 change in UNOS status classifica-
tion). 
All of the variables, except encephalopathy, are significant 
univariate predictors for blood loss; all 13 variables are signif-
icant for ICU days, and all but albumin, bilirubin, and inter-
national normalized ratio, are significant predictors of early 
complications. No variable was significantly predictive of 
complications occurring >30 days after OLT. However, nutri-
tional status was the preoperative factor closest to statistical 
significance (P = .075) for prediction of complications >30 
days after OLT. 
Multivariate Analysis. The multivariate analysis is pre-
TABLE 4. Regression Coefficients for Blood Usage, ICU Days, and Complications Within 30 Days of OLT Surgery for Patients Who Underwent 
Liver Transplantation for PBC or PSC 
Complications :s30 
Blood Usage* ICUDays" days* 
Regression Regression Regression 
Coefficient SE P§ Coefficient SE P§ Coefficient SE 
Intercept 0.98 0.79 0.60 
\i{c Iy) 0.01 0.00 .017 (J.01 (J.OO .004 0.02 0.01 
. "'nal failure** 0.19 0.17 .255 0.63 0.16 <.001 0.53 0.23 
( 'hild's Classt 0.29 0.07 <.001 0.25 0.07 <.001 0.12 0.13 
UNOS status:j: -0.21 0.06 <.001 -0.19 0.06 .001 -0.19 0.11 
BUMC vs. Mayo# -1.34 0.13 < .001 -0.10 0.12 .380 -0.05 0.21 
Univ. Pitt. vs. Mayo## -0.38 0.14 .006 0.45 0.13 <.001 -0.30 0.2:3 
PBC vs. PSC@ 0.04 0.09 .608 0.08 0.09 .373 -0.11 0.17 
* Dependent variable in regression models. log transformation used for blood usage and ICU days. 
** Coded: 0 for normal renal function and 1 for renal failure (creatinine mg/dL >2.0 andlor urine output'" 10 mUkg-/24 hr,1. 
t Coded: 1 for Child's A or modified Child's os7: 2 for Child's B or modified Child's >7 and <..11: and :3 lilT Child's C or modllit'd Child's c-ll. 
:j: Coded: 1) [CUlliver failure; 2) hospitalized; 3) continuous care: and 4) at home. 
§ Two-tailed P value test if regression coefficient = O. 
# Mayo coded as 0 and BUMC coded as l. 
## Mayo coded as 0 and Univ. Pitt coded as 1. 
@ PSC coded as 0 and PBC coded as 1. 
P§ 
.020 
.021 
.354 
.084 
.796 
.196 
.522 
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sented in Tables 4 and 5. As no variable was predictive of 
late-term (>30 days) severe complications, we did not ana-
lyze further that outcome. Because the predictor variables 
are correlated, multiple combinations of different indepen-
dent variables can be incorporated into models that carry 
essentially the same predictive accuracy. In order to develop 
a final model that was simple to use, we examined models 
containing only four or fewer variables. Using the bootstrap 
method described earlier, 11 three-variable and 89 four-vari-
able models were indistinguishable from the "best" four-vari-
able multivariate model for ICU days, found by stepwise re-
gression. For prediction of the other two outcomes, we 
obtained the following: 2 three-variable and 38 four-variable 
models (blood loss) and 2 three-variable and 25 four-variable 
models (complications in the first 30 days of transplant). Only 
four of all four-variable models predicted all three outcomes 
within 0.5 SE of the regression coefficient. The highest rank-
ing model among these included age, renal failure, Child's 
class, and UNOS status. Table 4 shows the regression coeffi-
cients, the standard errors, and the P values for this model. 
Statistically significant differences in outcomes among insti-
tutions are believed to be secondary to different practices for 
data collection and coding. 
Calculation of Outcome Score and Effect. A score can be 
calculated from the four-variable model to predict the effect 
on outcome for any particular combination of preoperative 
factors. The patient's age is in years; the presence of renal 
failure is coded as 1, while its absence is zero; numerical 
values of 1, 2, 3 are attributed to Child's class A, B, and C, 
respectively; UNOS is coded as the following: 1) ICUlliver 
failure, 2) hospitalized, 3) continuous care, and 4) at home. 
The following formulas are used to calculate the score for 
each outcome: 
Blood Usage Score: -45 + (1 X age) + (19 x renal failure) 
+ (29 x Child's class) - (21 x UNOS status). 
lCU Score: -48 + (1.1 X age) + (63 x renal failure) + (25 
X Child's class) - (19 X UNOS status). 
Complications Score: -57 + (1.8 X age) + (53 X renal 
failure) + (12 X Child's class) - (19 X UNOS status). 
The size of the multiplicative effect is calculated as: 
exp (scoreIlOo). 
Table 5 shows the calculation for two hypothetical subjects. 
For the first patient, we expect that the use of intraoperative 
blood products will increase by 36%, the number of ICU days 
will increase by 35%, and the number of major complications 
in the first 30 days after OLT will increase by 45%. These 
changes pertain to the "average" patient who has been defined 
by the authors to be the following: 50 years old, Child B, not 
hospitalized but having continuous medical care (UNOS sta-
tus 3), and with normal renal function. A patient with more 
advanced liver disease (Child class C, instead of B), worse 
UNOS status, and the presence of renal failure is expected to 
have a more negative outcome as shown in Example 2. 
DISCUSSION 
The sUI'vival of patients transplanted for PBC and PSC 
has improved to such an extent (2-year patient survival 90<;f, 
and graft survival 82'k) that it is no longer a concern for 
medical research. Thus, the focus of this study is the morbid-
ity of the patient in the post-liver transplant period. Several 
authors have reported on pretransplantation factors that 
might predict less favorable outcomes after liver transplant. II . I :l 
These ,'eports have referred most often to series of patients 
who had mixed etiologies of end-stage liver disease. We chose 
to study 13 easily obtainable variables in a homogeneous 
!,,'1'OUp of patients (with cholestatic liver diseases) undergoing 
OLT. We chose these variables because the existing literature 
supports their association with the outcome of liver trans-
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plantation. We studied intraoperative blood loss, number of 
days in ICU, and severe complications occurring within and 
after 30 days from transplantation. We agree with a recent 
report by Clavi en et aI., [4 that there is a need to accurately 
define and standardize the complications occurring post-OLT 
to compare outcome studies from different transplant cen-
ters. To accomplish this, we chose a simple definition of se-
vere complication that is easily applicable at different trans-
plant centers. 
In our study, we found that several preoperative factors 
predict intraoperative blood loss, ICU stay, and severe com-
plications occurring in the first month following liver trans-
plantation. These factors lose their predictive value for com-
plications that occur >30 days after OLT. However, 
pretransplantation nutritional status almost reached statis-
tical significance in predicting late-term severe complica-
tions. A more definite evidence of a relationship between pre-
operative malnutrition and post-OLT outcome has been 
shown by Pikul et al. [5 
Our prognostic model includes age, renal failure, Child's 
class, and UNOS status. Other four-variable models were 
formulated during the multivariate analysis that were 
equally accurate from the statistical point of view for the 
purpose of predicting outcome. However, this model contains 
variables that are readily obtainable from the medical record 
and is easy to use by the liver transplant physician. 
It is evident that the heaviest weight is given to the pres-
ence or absence of renal failure (creatinine> 2 mg!dL), as 
shown by its higher regression coefficient, and this is in 
agreement with the literature. Cuervas-Mons et al. 11 found 
that preoperative serum creatinine level greater than 1.7 mg! 
dL could predict survival or death in 79% of the cases. Baliga 
et al. 12 reported that serum creatinine level at the time of 
placement on the transplant waiting list, and the hospitaliza-
tion status immediately pretransplant were related to early 
postoperative sepsis and hospital death. Those findings have 
been confirmed more recently by Doyle et a1. 13 in a prospec-
tive study. They reported that preoperative serum creatinine 
levels and the need for retransplantation were important pre-
dictors of graft failure. Mor et a1. [6 found that elevated serum 
creatinine, decreased platelets, and a prolonged partial 
thromboplastin time were risk factors for increased intraop' 
erative blood loss. A recent and refined analysis of the efled 
of pretransplantation renal function on outcome has been 
published by Gonwa et alY In a very large series, patients 
with renal failure secondary to hepatorenal syndrome were 
separated from those with other causes of renal dysfunction. 
They confirmed their previous finding that hepatorenal syn-
drome negatively influences survival, but they could not show 
an effect of preoperative renal function (defined by either 
glomerular filtration rate or serum creatinine) on outcome, 
in the group of patients who did not have hepatorenal syn, 
drome. This, as acknowledged by the authors, could be ex-
plained by the fact that the only outcome studied was sur-
vival. In a previous study, the same group demonstrated that 
preoperative renal failure was associated with increased rat(' 
of infection and intraoperative blood loss.l~ Thus, renal dl"-
function may be a risk factor for post-OLT morbiditv :IIHi 
could be an indirect risk factor for increased mortality. I" 
our series (436 patients), there were 40 patients (9'J,) Illth 
renal failure, of which only one was known to have hepatof'(" 
nal syndrome. Given these findings, we think it is important 
to prevent or treat preoperatively renal dysfunction in the 
individual patient. There is also a need to define which under-
lying pathophysiological mechanisms determine a negativ{' 
outcome in patients with renal dysfunction. 
Preoperative recipient physiology, assessed by either thl' 
APACHE II or the UNOS scoring system, is not only a pI'!' 
mary determinant of survival and cost, I~j but also a pn·dicto r 
of morbidity after liver transplantation. co Child-Pugh class 
_____ ~ _ _"" __ • __ " ....... "'_ • ______ ... __ ....,....-...-~~,·......___ •• ___ ............. s ______ _" ___ ..,.~" ..... -....._._ ••• ,.--.,. v 
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has also been associated with post-OLT morbidity in terms 
of need for dialysis and infections. 12 This study has confirmed 
that both UNOS status and Child class at the time of trans-
plantation are important predictors of morbidity in patients 
undergoing OLT for PEC or PSC, Finally, it is interesting to 
note that regression coefficients for prediction of ICU days 
and complications in the first 30 days' post-OLT are very 
close in value, This indirectly supports the validity of the 
definition of "severe" complications chosen for our study, 
Clinicians using these models should recognize that, in gen-
eral, the precision of prognostic models in predicting outcome 
is greatest in the average patient. However, in the individual 
patient, the predicted outcomes may be imprecise, ie, have a 
wider error, Also, as a risk factor can vary among patients, the 
corresponding confidence limits for prediction at the individual 
level can vary as well. Our patient database and post-OLT 
outcomes are derived from transplant centers performing a 
large number of transplants each year. Thus our patient series 
is representative of the general population of patients that un-
dergo OLT for PEC and PSC at established transplantation 
centers. External validation, as with any new prognostic model, 
is needed to establish this methodology. 
CONCLUSION 
In patients with PEC and PSC many preoperative vari-
ables predict intraoperative blood loss, ICU stay, and morbid-
ity in the first 30 days' post-OLT. We have presented a new 
mathematical model that utilizes age, Child class, UNOS sta-
tus and renal failure to predict which patients undergoing 
OLT will have a more favorable outcome. This model has 
been developed on a relatively large number of patients un-
dergoing OLT at three major medical centers. 
As with other mathematical models, the intention is to 
assist the physician in the clinical assessment of patient se-
lection and timing of OLT without replacing clinical judge-
ment. This model has been obtained from patients with chole-
static liver diseases and to date has not been tested in 
patients with other liver diseases. 
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